Rossari Historical Cash Flow

ROSSARI Stock   796.95  3.50  0.44%   
Analysis of Rossari Biotech cash flow over time is an excellent tool to project Rossari Biotech future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Total Cash From Operating Activities of 589.9 M or Net Income of 991.1 M as it is a great indicator of Rossari Biotech ability to facilitate future growth, repay debt on time or pay out dividends.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rossari Biotech Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

About Rossari Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in Rossari balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Rossari's non-liquid assets can be easily converted into cash.

Rossari Biotech Cash Flow Chart

As of now, Rossari Biotech's End Period Cash Flow is increasing as compared to previous years. The Rossari Biotech's current Other Cashflows From Investing Activities is estimated to increase to about 480.9 M, while Change To Inventory is forecasted to increase to (891.6 M).

Free Cash Flow

The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.

Total Cashflows From Investing Activities

The net amount of cash used in or generated from a company's investment activities, such as purchasing or selling assets, during a reporting period.

Dividends Paid

The total amount of dividends that a company has paid out to its shareholders over a specific period.

Capital Expenditures

Capital Expenditures are funds used by Rossari Biotech to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Rossari Biotech operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.

Stock Based Compensation

Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.
Most accounts from Rossari Biotech's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Rossari Biotech current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rossari Biotech Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
As of now, Rossari Biotech's End Period Cash Flow is increasing as compared to previous years. The Rossari Biotech's current Other Cashflows From Investing Activities is estimated to increase to about 480.9 M, while Change To Inventory is forecasted to increase to (891.6 M).

Rossari Biotech cash flow statement Correlations

0.180.710.210.70.94-0.87-0.630.42-0.890.96-0.64-0.30.630.35-0.01-0.62
0.180.06-0.39-0.10.24-0.56-0.5-0.01-0.50.35-0.42-0.620.110.45-0.540.11
0.710.060.340.80.59-0.63-0.070.12-0.590.77-0.020.30.30.06-0.45-0.14
0.21-0.390.34-0.070.07-0.2-0.10.160.030.16-0.120.110.65-0.34-0.19-0.47
0.7-0.10.8-0.070.68-0.46-0.010.15-0.620.69-0.050.30.10.2-0.05-0.2
0.940.240.590.070.68-0.87-0.710.17-0.830.91-0.67-0.440.630.640.12-0.68
-0.87-0.56-0.63-0.2-0.46-0.870.76-0.210.88-0.920.710.55-0.72-0.530.30.57
-0.63-0.5-0.07-0.1-0.01-0.710.76-0.210.64-0.620.930.88-0.74-0.59-0.10.66
0.42-0.010.120.160.150.17-0.21-0.21-0.50.24-0.47-0.130.21-0.38-0.04-0.29
-0.89-0.5-0.590.03-0.62-0.830.880.64-0.5-0.90.710.45-0.53-0.340.240.49
0.960.350.770.160.690.91-0.92-0.620.24-0.9-0.57-0.310.60.39-0.18-0.49
-0.64-0.42-0.02-0.12-0.05-0.670.710.93-0.470.71-0.570.86-0.76-0.44-0.10.77
-0.3-0.620.30.110.3-0.440.550.88-0.130.45-0.310.86-0.57-0.59-0.10.55
0.630.110.30.650.10.63-0.72-0.740.21-0.530.6-0.76-0.570.28-0.05-0.88
0.350.450.06-0.340.20.64-0.53-0.59-0.38-0.340.39-0.44-0.590.280.2-0.37
-0.01-0.54-0.45-0.19-0.050.120.3-0.1-0.040.24-0.18-0.1-0.1-0.050.2-0.31
-0.620.11-0.14-0.47-0.2-0.680.570.66-0.290.49-0.490.770.55-0.88-0.37-0.31
Click cells to compare fundamentals

Rossari Biotech Account Relationship Matchups

Rossari Biotech cash flow statement Accounts

201920202021202220232024 (projected)
Change To Inventory(37.7M)(320.3M)(481.9M)7.3M(938.5M)(891.6M)
Investments(1.2B)195.3M799.6M(1.8B)(1.0B)(980.5M)
Change In Cash234.7M(140.0M)222.7M323.6M(440.3M)(418.3M)
Net Borrowings(164.2M)628.9M(610.1M)(48.1M)(43.3M)(45.5M)
Free Cash Flow(211.4M)(103.2M)(88.7M)1.2B(880.3M)(836.3M)
Change In Working Capital(310.7M)(483.1M)(1.1B)(272.0M)(1.6B)(1.5B)
Begin Period Cash Flow57.4M292.1M152.1M374.8M692.0M726.6M
Total Cashflows From Investing Activities(364.2M)(1.9B)(371.8M)(3.0B)(2.7B)(2.6B)
Other Cashflows From Financing Activities1.6B2M2.9B594.0M(168.0M)(159.6M)
Depreciation168.5M228.3M480.6M629.3M603.9M320.2M
Other Non Cash Items20.1M(12.7M)85.9M197.9M81.1M53.1M
Dividends Paid105.9M26.5M25.4M27.5M(27.6M)(26.2M)
Capital Expenditures759.7M580.8M382.3M328.8M1.3B1.4B
Total Cash From Operating Activities548.3M477.7M293.6M1.5B432.6M589.9M
Change To Account Receivables(204.1M)(404.5M)(425.3M)(279.7M)(1.1B)(1.1B)
Net Income880.6M1.1B1.4B1.4B1.3B991.1M
Total Cash From Financing Activities1.6B(245.9M)2.9B608.6M161.9M153.8M
End Period Cash Flow292.1M152.1M374.8M698.3M251.7M254.9M
Other Cashflows From Investing Activities15.0M35.3M49.7M(494.9M)458.0M480.9M
Change To Netincome18.4M57.9M(69.8M)(33.8M)(30.4M)(28.9M)
Change To Liabilities672.2M(69.0M)241.7M(222.8M)(200.5M)(190.5M)
Sale Purchase Of Stock(975.8M)(309.5M)(3.0B)(655.0M)(589.5M)(619.0M)
Issuance Of Capital Stock1B426.5M3.0B42.1M38.5M36.5M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Rossari Stock

The Cash Flow Statement is a financial statement that shows how changes in Rossari balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Rossari's non-liquid assets can be easily converted into cash.